Create and deliver personalized experiences across digital properties at scale
Build engaging websites with intuitive web content management
Leverage a complete UI toolbox for web, mobile and desktop development
Build, protect and deploy apps across any platform and mobile device
Build mobile apps for iOS, Android and Windows Phone
Rapidly develop, manage and deploy business apps, delivered as SaaS in the cloud
Automate UI, load and performance testing for web, desktop and mobile
Host, deploy and scale Node.js, Java and .NET Core apps on premise or in the cloud
Optimize data integration with high-performance connectivity
Automate decision processes with a no-code business rules engine
Transform your businesses in order to survive in a completely digitized and connected world driven by software innovation.
Globally scale websites with innovative content management and infrastructure approaches
Content-focused web and mobile solution for empowering marketers
Faster, tailored mobile experiences for any device and data source
UX and app modernization to powerfully navigate today's digital landscape
Fuel agility with ever-ready applications, built in the cloud
Progress offers best-of-breed technology components covered under the A-87 Exception.
On July 20, 2015, the Centers for Medicare & Medicaid Services (CMS), the Administration for Children and Families (ACF) and the USDA Food and Nutrition Service (FNS) released guidance to States on the OMB Circular A-87 Cost Allocation Exception. This document clarifies the process to take advantage of enhanced federal funding to modernize and integrate benefits eligibility and administration systems.
Enhanced federal funding encourages states to implement and use best-of-breed architecture and technology components across Affordable Care Act (ACA) programs, as well as other benefit programs not directly related to ACA. Examples of covered technology components include client portals, user interfaces and business rules engines.
Incidentally, Progress offers best-of-breed technology components covered under the A-87 Exception. These products are used by more than 50 percent of the states in the U.S. and include the following:
As more and more governmental organizations across the country modernize and consolidate systems to simplify benefits eligibility determination and administration, they’ll need to take advantage of the A-87 exception to upgrade their technology platforms and tools. This will enable a more streamlined experience for citizens, and more cost-effective use of governmental resources. Most importantly, these solutions will enable faster and more accurate distribution of benefits to the people who need them, such as Medicaid and Medicare patients, and recipients of other programs such as SNAP, WIC, and others.
Interested in learning more? We will be showcasing Corticon at the upcoming APHSA ISM event on August 30-September 2 at booth #705. We hope to see you there. But just in case you aren’t able to make it, hear it straight from Jim Weaver, Deputy CIO at the Commonwealth of Pennsylvania – Department of Public Welfare, in a recent webinar recording.
Dr. Mark Allen is a Progress General Manager, dedicated to advancing business automation and passionate about applying technology to improve the world. In 2000, he founded Corticon, later acquired by Progress in 2011. Under his leadership, Corticon became a leading independent business rules platform with hundreds of customers in diverse industries such as financial services, government, healthcare and insurance. Prior to founding Corticon, Dr. Allen developed rules-based systems to help physicians make better patient care decisions. Dr. Allen has a B.S. in Applied Physics from Columbia University, and an M.D. from the University of California Los Angeles.
Copyright © 2016, Progress Software Corporation and/or its subsidiaries or affiliates.
All Rights Reserved.
Progress, Telerik, and certain product names used herein are trademarks or registered trademarks of Progress Software Corporation and/or one of its subsidiaries or affiliates in the U.S. and/or other countries. See Trademarks or appropriate markings.